Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
10/2022 ceased to operate
BioShai
BioShai Overview
BioShai is developing PDx, a simple blood test for the early diagnosis of Parkinsons disease. PDx is based on the measurement of the level of expression of a set of genes. The test can be combined with other clinical data to provide a more complete diagnosis and help physicians decide on the best course of treatment.
BioShai is a portfolio company of Youdim Pharmaceuticals incubator.
BioShai Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 17, 2016
www.israel21c.org
World's first blood test to aid diagnosis of Parkinson's